
Although most solid tumors are treated zzso determining the genetic changes present in the tumor of an individual patient is becoming increasingly important for managing the zzso zzso Our knowledge of the genetic zzso that characterize and zzso to solid tumors continues to zzso zzso the advent of newer technologies such as DNA chips has the potential to enable a more rapid and comprehensive assessment of these zzso The ultimate goal of this new information and technology is to provide sensitive and specific tests that reduce unnecessary procedures and zzso zzso This review addresses the utility of molecular testing in evaluating zzso A review of the current technology and zzso cancer syndromes is also zzso 

